Shanghai Fosun Pharmaceutical (02196)s controlling shareholder, Shanghai Fosun High Technology, has released the pledge of 103 million A shares and 32 million shares.

Shanghai Fosun Pharmaceutical (02196) announced that on January 23, 2026, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (hereinafter referred to as "the Company") received a notification from its controlling shareholder, Shanghai Fosun High-Tech (Group) Co., Ltd. (hereinafter referred to as "Fosun High-Tech"), that it has pledged and released a portion of its A shares in the Company. The number of shares pledged this time is 32 million shares, accounting for 3.33% of its total shareholding and 1.20% of the total shares of the company. The controlling shareholder Fosun High-Tech has released a total of 103 million shares (all A shares) from pledge, effective on January 22, 2026. The remaining pledged shares are 476 million shares (all A shares).